Tabula Rasa HealthCare Statistics
Share Statistics
Tabula Rasa HealthCare has 27.05M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding | 27.05M |
Shares Change (YoY) | 0% |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | n/a |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 11,446 |
FTD / Avg. Volume | 2.55% |
Short Selling Information
Short Interest | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -1.55 and the forward
PE ratio is null.
Tabula Rasa HealthCare's PEG ratio is
0.25.
PE Ratio | -1.55 |
Forward PE | n/a |
PS Ratio | 0.4 |
Forward PS | n/a |
PB Ratio | -2.11 |
P/FCF Ratio | -5.62 |
PEG Ratio | 0.25 |
Financial Ratio History Enterprise Valuation
Tabula Rasa HealthCare has an Enterprise Value (EV) of 386.36M.
EV / Sales | 1.29 |
EV / EBITDA | -15.68 |
EV / EBIT | 52.52 |
EV / FCF | -18.07 |
Financial Position
The company has a current ratio of 1.67,
with a Debt / Equity ratio of -4.34.
Current Ratio | 1.67 |
Quick Ratio | 1.6 |
Debt / Equity | -4.34 |
Debt / EBITDA | -13.64 |
Debt / FCF | -15.72 |
Interest Coverage | -6.24 |
Financial Efficiency
Return on Equity is 135.6% and Return on Invested Capital is -29.73%.
Return on Equity | 135.6% |
Return on Assets | -20.13% |
Return on Invested Capital | -29.73% |
Revenue Per Employee | $291,641.67 |
Profits Per Employee | $-75,300.88 |
Employee Count | 1,027 |
Asset Turnover | 0.78 |
Inventory Turnover | 35.43 |
Taxes
Income Tax | 389K |
Effective Tax Rate | -0.51% |
Stock Price Statistics
The stock price has increased by 0% in the
last 52 weeks. The beta is 1.58, so Tabula Rasa HealthCare's
price volatility has been higher than the market average.
Beta | 1.58 |
52-Week Price Change | n/a |
50-Day Moving Average | 10.36 |
200-Day Moving Average | 7.66 |
Relative Strength Index (RSI) | 75.14 |
Average Volume (20 Days) | 449,190 |
Income Statement
In the last 12 months, Tabula Rasa HealthCare had revenue of 299.52M
and earned -77.33M
in profits. Earnings per share was -3.18.
Revenue | 299.52M |
Gross Profit | 66.91M |
Operating Income | -56.38M |
Net Income | -77.33M |
EBITDA | -24.64M |
EBIT | -58.88M |
Earnings Per Share (EPS) | -3.18 |
Full Income Statement Balance Sheet
The company has 70.02M in cash and 336.13M in
debt, giving a net cash position of -266.11M.
Cash & Cash Equivalents | 70.02M |
Total Debt | 336.13M |
Net Cash | -266.11M |
Retained Earnings | -407.86M |
Total Assets | 355.94M |
Working Capital | 52.99M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 7.36M
and capital expenditures -28.74M, giving a free cash flow of -21.38M.
Operating Cash Flow | 7.36M |
Capital Expenditures | -28.74M |
Free Cash Flow | -21.38M |
FCF Per Share | -0.88 |
Full Cash Flow Statement Margins
Gross margin is 22.34%, with operating and profit margins of -18.82% and -25.82%.
Gross Margin | 22.34% |
Operating Margin | -18.82% |
Pretax Margin | -25.69% |
Profit Margin | -25.82% |
EBITDA Margin | -8.23% |
EBIT Margin | -18.82% |
FCF Margin | -7.14% |